Company / Shareholders' Equity
Beam Therapeutics Inc. Shareholders' Equity History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$1.2B
FY2025
5-year range
$733.5M / $1.2B
FY2021-FY2025
Trend
+68.8%
vs FY2024
Sector context
#37 of 213
Health Care
What the data says
Beam Therapeutics Inc.'s shareholders' equity of $1.2B is higher than 83% of companies in the Health Care sector (FY2025). Shareholders' Equity has fluctuated over the past 7 years, ranging from -$201M in FY2019 to $1.2B in FY2025.
Based on SEC 10-K filings.
$1.2B in FY2025 with a 3-year CAGR of +19.1%. Top quartile in the Health Care sector.
Improved from $981M to $1.2B over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +19.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
-51.4% below sector average
Key checks
Key Insights
- 3-year CAGR of +19.1%, indicating consistent growth.
- In FY2025, shareholders' equity increased 68.8% year-over-year.
- Ranks #37 out of 213 companies in the Health Care sector.
- Lowest shareholders' equity in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.2B | +68.8% |
| FY2024 | $733.5M | -25.2% |
| FY2023 | $981.3M | +33.8% |
| FY2022 | $733.5M | -11.3% |
| FY2021 | $826.7M | +804.2% |
| FY2020 | -$117.4M | +41.6% |
| FY2019 | -$201.1M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026